Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA

Rothman Institute Orthopaedics156 enrolled

Overview

A non-blinded randomized controlled trial, in which participants undergoing primary reverse or total shoulder arthroplasty are randomly assigned to one of two treatment groups.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

156

Conditions

Osteoarthritis: Shoulder

Interventions

Interscalene brachial plexus blockPROCEDURE

bupivacaine extended-release liposome injectionPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1\. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital. Exclusion Criteria: 1. Psychiatric illness as defined by co-morbid diagnosis of bipolar disorder or schizophrenia 2. Revision arthroplasty, arthroplasty for fracture 3. Unable/unwilling to consent for enrollment 4. Unable to complete postoperative pain survey 5. Known adverse drug reaction or allergy to the medications used 6. Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain) 7. Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone). 8. Patients under the age of 18 years 9. Patients with history of hepatic disease 10. Pregnant women or women who are breastfeeding

Outcomes

Primary Outcomes

Morphine and Morphine Equivalent consumption

Time frame: 24 hours following surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.